Cargando…

Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy

Platinum-based chemotherapy remains the cornerstone of treatment for most non-small cell lung cancer (NSCLC) cases either as maintenance therapy or in combination with immunotherapy. However, resistance remains a primary issue. Our findings point to the possibility of exploiting levels of cell divis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kildey, Katrina, Gandhi, Neha S., Sahin, Katherine B., Shah, Esha T., Boittier, Eric, Duijf, Pascal H. G., Molloy, Christopher, Burgess, Joshua T., Beard, Sam, Bolderson, Emma, Suraweera, Amila, Richard, Derek J., O’Byrne, Kenneth J., Adams, Mark N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163776/ https://www.ncbi.nlm.nih.gov/pubmed/34050247 http://dx.doi.org/10.1038/s42003-021-02136-8

Ejemplares similares

Structural investigation of CDCA3‐Cdh1 protein–protein interactions using in vitro studies and molecular dynamics simulation
por: Barbhuiya, Tabassum Khair, et al.
Publicado: (2023)

Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer
por: Ryan, Sarah-Louise, et al.
Publicado: (2021)

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer
por: Sahin, Katherine B., et al.
Publicado: (2021)

COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaks
por: Suraweera, Amila, et al.
Publicado: (2021)

Chemotherapeutic Compounds Targeting the DNA Double-Strand Break Repair Pathways: The Good, the Bad, and the Promising
por: Jekimovs, Christian, et al.
Publicado: (2014)

Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
por: Suraweera, Amila, et al.
Publicado: (2020)

Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
por: Suraweera, Amila, et al.
Publicado: (2021)

Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy
por: Sobanski, Thais, et al.
Publicado: (2021)

Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity
por: Burgess, Joshua T, et al.
Publicado: (2021)

COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic Target
por: Suraweera, Amila, et al.
Publicado: (2021)

Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage
por: Bolderson, Emma, et al.
Publicado: (2019)

The Impact of Rare Human Variants on Barrier-To-Auto-Integration Factor 1 (Banf1) Structure and Function
por: Rose, Maddison, et al.
Publicado: (2021)

The fructose-bisphosphate, Aldolase A (ALDOA), facilitates DNA-PKcs and ATM kinase activity to regulate DNA double-strand break repair
por: Sobanski, Thais, et al.
Publicado: (2023)

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
por: Suraweera, Amila, et al.
Publicado: (2018)

SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer
por: Burgess, Joshua T., et al.
Publicado: (2020)

Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review
por: Fernandez, Alejandra, et al.
Publicado: (2021)

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
por: Rose, Maddison, et al.
Publicado: (2020)

The role of inner nuclear membrane proteins in tumourigenesis and as potential targets for cancer therapy
por: Rose, Maddison, et al.
Publicado: (2022)

An Exploration of Small Molecules That Bind Human Single-Stranded DNA Binding Protein 1
por: Schuurs, Zachariah P., et al.
Publicado: (2023)

Néstor-Guillermo Progeria Syndrome: a biochemical insight into Barrier-to-Autointegration Factor 1, alanine 12 threonine mutation
por: Paquet, Nicolas, et al.
Publicado: (2014)

hSSB1 (NABP2/ OBFC2B) is required for the repair of 8-oxo-guanine by the hOGG1-mediated base excision repair pathway
por: Paquet, Nicolas, et al.
Publicado: (2015)

Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics
por: Richard, Iain A., et al.
Publicado: (2022)

Stochastic epithelial-mesenchymal transitions diversify non-cancerous lung cell behaviours
por: Bhatia, Sugandha, et al.
Publicado: (2023)

The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
por: Burgess, Joshua T., et al.
Publicado: (2020)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

Tumor Hypoxia Drives Genomic Instability
por: Tang, Ming, et al.
Publicado: (2021)

hSSB1 (NABP2/OBFC2B) is regulated by oxidative stress
por: Paquet, Nicolas, et al.
Publicado: (2016)

Human single-stranded DNA binding protein 1 (hSSB1/NABP2) is required for the stability and repair of stalled replication forks
por: Bolderson, Emma, et al.
Publicado: (2014)

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response
por: Burgess, Joshua T, et al.
Publicado: (2016)

Human single-stranded DNA binding proteins are essential for maintaining genomic stability
por: Ashton, Nicholas W, et al.
Publicado: (2013)

Nucleophosmin: from structure and function to disease development
por: Box, Joseph K., et al.
Publicado: (2016)

Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are “More Equal” than Others
por: Boittier, Eric D., et al.
Publicado: (2019)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

hSSB1 associates with and promotes stability of the BLM helicase
por: Croft, Laura V., et al.
Publicado: (2017)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

Assessing Molecular Docking Tools to Guide Targeted Drug Discovery of CD38 Inhibitors
por: Boittier, Eric D., et al.
Publicado: (2020)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

Spatial Profiling Identifies Prognostic Features of Response to Adjuvant Therapy in Triple Negative Breast Cancer (TNBC)
por: Kulasinghe, Arutha, et al.
Publicado: (2022)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34f8hb8vneoh070mrb2k73kdbs